| Thu | ||
|---|---|---|
Start: 12:00 am
End: 5:00 pm
Location: Kohala Coast, Big Island, Hawaii This program addresses that need with the latest information on acute MI, risk management, valvular and coronary artery disease, interventional cardiology, congestive heart failure, arrhythmias, lipid management, peripheral vascular disease, and diabetes. Faculty also will present recent advances in carotid stenting, gene testing, and pharmacologic management of cardiovascular disorders. Designed for cardiovascular specialists, cardiac nurses and technicians, this program provides a comprehensive update for diagnostic evaluation and medical/surgical treatment of cardiovascular disease. Participants can take advantage of this opportunity to learn about advances in general cardiovascular disease and enjoy the beautiful island of Hawaii. Start: 8:00 am
End: 5:00 pm
Location: Ritz Carlton, Amelia Island, FL The Drug Development Summit is a one-of-a kind event that brings together key R&D professionals from leading pharmaceutical and biotech companies to discuss decisions and strategies leading to their winning pipelines. R&D Directions’ 5th Annual Drug Development Summit provides a forum for senior level research and development executives to share insights, compare strategies, and make connections with key opinion leaders. Built around the Top Ten Pipelines issue of R&D Directions, the summit provides a strategic approach to tackling R&D's critical issues in 2008. Benchmark your approach for improved efficiency and cost effectiveness while ensuring safety in the research and development of drugs against your fellow leaders. Among the issues addressed at this year's summit are: Start: 8:00 am
End: 5:00 pm
Location: San Francisco Marriott, San Francisco, CA This three-day multidisciplinary symposium is your best opportunity to learn about the newest strategies in prevention, screening, diagnosis, and treatment of genitourinary cancers. Expanding on The Prostate Cancer Symposium, this new symposium offers educational sessions and abstract oral and poster presentations focused on GU cancers of the testis, bladder, kidney, and prostate organs. | ||